Association between inpatient education program for patients with pre-dialysis chronic kidney disease and new-onset cardiovascular disease after initiating dialysis.


Journal

Clinical and experimental nephrology
ISSN: 1437-7799
Titre abrégé: Clin Exp Nephrol
Pays: Japan
ID NLM: 9709923

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 28 05 2023
accepted: 19 08 2023
medline: 17 11 2023
pubmed: 1 9 2023
entrez: 1 9 2023
Statut: ppublish

Résumé

The association between inpatient education programs (IEPs) for patients with pre-dialysis chronic kidney disease (CKD) and new-onset cardiovascular disease (CVD) after initiating dialysis is unclear. We conducted a retrospective cohort study between January 1, 2011 and December 31, 2018, evaluating CKD patients who were divided into two groups based on whether or not they participated in IEPs. The primary outcome was a new-onset CVD event after initiating dialysis. Cumulative incidence function was used to describe new-onset CVD considering the competing outcome of death. Additionally, Cox proportional hazards models were used to estimate the hazard ratio of new-onset CVD between IEP and non-IEP groups. Of the 493 patients, 131 (26.6%) patients had participated in IEPs. The IEP group had a significantly longer duration of CKD management by nephrologists (median 142 vs. 115 days, P = 0.007), lower rate of emergency hospital admissions (9.9% vs. 27.1%, P < 0.001), better ability to perform activities of daily living (Grade J; 81.6% vs. 69.1%, P = 0.046), higher rate of pre-placement of permanent vascular access or peritoneal dialysis catheters (82.4% vs. 59.4%, P < 0.001), and a higher serum albumin level at the beginning of dialysis (3.5 ± 0.5 vs. 3.3 ± 0.6 g/dL, P < 0.001). The cumulative incidence of new-onset CVD at three years after initiating dialysis in the IEP and non-IEP groups was 16.9% and 22.5%, respectively. The hazard ratio for new-onset CVD after initiating dialysis in the IEP group was 0.63 (95% CI: 0.41-0.97, P = 0.036). IEPs were associated with a lower rate of new-onset CVD after initiating dialysis.

Sections du résumé

BACKGROUND BACKGROUND
The association between inpatient education programs (IEPs) for patients with pre-dialysis chronic kidney disease (CKD) and new-onset cardiovascular disease (CVD) after initiating dialysis is unclear.
METHODS METHODS
We conducted a retrospective cohort study between January 1, 2011 and December 31, 2018, evaluating CKD patients who were divided into two groups based on whether or not they participated in IEPs. The primary outcome was a new-onset CVD event after initiating dialysis. Cumulative incidence function was used to describe new-onset CVD considering the competing outcome of death. Additionally, Cox proportional hazards models were used to estimate the hazard ratio of new-onset CVD between IEP and non-IEP groups.
RESULTS RESULTS
Of the 493 patients, 131 (26.6%) patients had participated in IEPs. The IEP group had a significantly longer duration of CKD management by nephrologists (median 142 vs. 115 days, P = 0.007), lower rate of emergency hospital admissions (9.9% vs. 27.1%, P < 0.001), better ability to perform activities of daily living (Grade J; 81.6% vs. 69.1%, P = 0.046), higher rate of pre-placement of permanent vascular access or peritoneal dialysis catheters (82.4% vs. 59.4%, P < 0.001), and a higher serum albumin level at the beginning of dialysis (3.5 ± 0.5 vs. 3.3 ± 0.6 g/dL, P < 0.001). The cumulative incidence of new-onset CVD at three years after initiating dialysis in the IEP and non-IEP groups was 16.9% and 22.5%, respectively. The hazard ratio for new-onset CVD after initiating dialysis in the IEP group was 0.63 (95% CI: 0.41-0.97, P = 0.036).
CONCLUSION CONCLUSIONS
IEPs were associated with a lower rate of new-onset CVD after initiating dialysis.

Identifiants

pubmed: 37656395
doi: 10.1007/s10157-023-02400-7
pii: 10.1007/s10157-023-02400-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1042-1050

Informations de copyright

© 2023. The Author(s), under exclusive licence to Japanese Society of Nephrology.

Références

Nagai K, Asahi K, Iseki K, et al. Estimating the prevalence of definitive chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2021;25:885–92.
doi: 10.1007/s10157-021-02049-0 pubmed: 33839966
Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17–28.
doi: 10.1038/ki.2010.483 pubmed: 21150873
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.
doi: 10.1056/NEJMoa041031 pubmed: 15385656
Tanaka K, Watanabe T, Takeuchi A, et al. Cardiovascular events and death in Japanese patients with chronic kidney disease. Kidney Int. 2017;91:227–34.
doi: 10.1016/j.kint.2016.09.015 pubmed: 27884399
Matsushita K, Ballew SH, Wang AYM, et al. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18:696–707.
doi: 10.1038/s41581-022-00616-6 pubmed: 36104509
Japanese Society of Nephrology. Essential points from evidence-based clinical practice guidelines for chronic kidney disease 2018. Clin Exp Nephrol. 2019;23:1–15.
doi: 10.1007/s10157-018-1648-1
Machida S, Shibagaki Y, Sakurada T. An inpatient educational program for chronic kidney disease. Clin Exp Nephrol. 2019;23:493–500.
doi: 10.1007/s10157-018-1660-5 pubmed: 30341571
Takagi WH, Osako K, Machida S, et al. Inpatient educational program delays the need for dialysis in patients with chronic kidney disease stage G5. Clin Exp Nephrol. 2021;25:166–72.
doi: 10.1007/s10157-020-01979-5 pubmed: 33040245
Yoshida K, Shimizu S, Kita Y, et al. Impact of inpatient educational programs on mortality after the start of dialysis therapy. Clin Exp Nephrol. 2022;26:819–26.
doi: 10.1007/s10157-022-02211-2 pubmed: 35333998
Kinugasa Y, Kato M, Sugihara S, et al. Multidisciplinary intensive education in the hospital improves outcomes for hospitalized heart failure patients in a Japanese rural setting. BMC Health Serv Res. 2014;14:351.
doi: 10.1186/1472-6963-14-351 pubmed: 25134951 pmcid: 4141092
Nitta K, Goto S, Masakane I, et al. Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality. Ren Replace Ther. 2020;6:41.
doi: 10.1186/s41100-020-00286-9
Nichols GA, Ustyugova A, Déruaz-Luyet A, et al. Health care costs by type of expenditure across eGFR stages among patients with and without diabetes, cardiovascular disease, and heart failure. J Am Soc Nephrol. 2020;31:1594–601.
doi: 10.1681/ASN.2019121308 pubmed: 32487562 pmcid: 7350988
Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.
doi: 10.1053/j.ajkd.2008.12.034 pubmed: 19339088
Ueno R, Hatta T, Kawasaki Y, et al. Effect of an educational admission program for patients at the conservative phase of chronic kidney disease (CKD). Nihon Jinzo Gakkai Shi. 2013;55:956–65 ((in Japanese)).
pubmed: 23980481
Hsu JY, Roy JA, Xie D, et al. Statistical methods for cohort studies of CKD: survival analysis in the setting of competing risks. Clin J Am Soc Nephrol. 2017;12:1181–9.
doi: 10.2215/CJN.10301016 pubmed: 28242844 pmcid: 5498354
Strand H, Parker D. Effects of multidisciplinary models of care for adult pre-dialysis patients with chronic kidney disease: a systematic review. Int J Evid Based Healthc. 2012;10:53–9.
doi: 10.1111/j.1744-1609.2012.00253.x pubmed: 22405416
Wang Q, Ge M, Sun H, et al. Systematic review and meta-analysis program based on effectiveness of a multidisciplinary model of care for patients with chronic kidney disease. Contrast Media Mol Imaging. 2022;2022:4315361.
pubmed: 35935312 pmcid: 9325573
Wang SM, Hsiao LC, Ting IW, et al. Multidisciplinary care in patients with chronic kidney disease: a systematic review and meta-analysis. Eur J Intern Med. 2015;26:640–5.
doi: 10.1016/j.ejim.2015.07.002 pubmed: 26186813
Shi Y, Xiong J, Chen Y, et al. The effectiveness of multidisciplinary care models for patients with chronic kidney disease: a systematic review and meta-analysis. Int Urol Nephrol. 2018;50:301–12.
doi: 10.1007/s11255-017-1679-7 pubmed: 28856498
Abe M, Hatta T, Imamura Y, et al. Effectiveness and current status of multidisciplinary care for patients with chronic kidney disease in Japan: a nationwide multicenter cohort study. Clin Exp Nephrol. 2023. https://doi.org/10.1007/s10157-023-02338-w .
doi: 10.1007/s10157-023-02338-w pubmed: 37924432 pmcid: 10192167
Hemmelgarn BR, Manns BJ, Zhang J, et al. Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. J Am Soc Nephrol. 2007;18:993–9.
doi: 10.1681/ASN.2006080860 pubmed: 17267742
van Zuilen AD, Bots ML, Dulger A, et al. Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease. Kidney Int. 2012;82:710–7.
doi: 10.1038/ki.2012.137 pubmed: 22739979
Yu YJ, Wu IW, Huang CY, et al. Multidisciplinary predialysis education reduced the inpatient and total medical costs of the first 6 months of dialysis in incident hemodialysis patients. PLoS ONE. 2014;9: e112820.
doi: 10.1371/journal.pone.0112820 pubmed: 25398129 pmcid: 4232513
Chen PM, Lai TS, Chen PY, et al. Multidisciplinary care program for advanced chronic kidney disease: reduces renal replacement and medical costs. Am J Med. 2015;128:68–76.
doi: 10.1016/j.amjmed.2014.07.042 pubmed: 25149427
Yamagata K, Makino H, Iseki K, et al. Effect of behavior modification on outcome in early- to moderate-stage chronic kidney disease: a cluster-randomized trial. PLoS ONE. 2016;11: e0151422.
doi: 10.1371/journal.pone.0151422 pubmed: 26999730 pmcid: 4801411
Onishi Y, Uchida HA, Maeshima Y, et al. The effect of medical cooperation in the CKD Patients: 10-year multicenter cohort study. J Pers Med. 2023;13:582.
doi: 10.3390/jpm13040582 pubmed: 37108968 pmcid: 10142789
Imasawa T, Saito C, Kai H, et al. Long-term effectiveness of a primary care practice facilitation program for chronic kidney disease management: an extended follow-up of a cluster-randomized FROM-J study. Nephrol Dial Transplant. 2023;38:158–66.
doi: 10.1093/ndt/gfac041 pubmed: 35195257
Howden EJ, Leano R, Petchey W, et al. Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clin J Am Soc Nephrol. 2013;8:1494–501.
doi: 10.2215/CJN.10141012 pubmed: 23970136 pmcid: 3805077
St Peter WL, Wazny LD, Patel UD. New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management. Curr Opin Nephrol Hypertens. 2013;22:656–62.
doi: 10.1097/MNH.0b013e328365b364 pubmed: 24076556 pmcid: 4012859
Nakai S, Masakane I, Shigematsu T, et al. An overview of regular dialysis treatment in Japan (As of 31 December 2007). Ther Apher Dial. 2009;13:457–504.
doi: 10.1111/j.1744-9987.2009.00789.x pubmed: 19954472

Auteurs

Shu Ushimaru (S)

Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.

Sayaka Shimizu (S)

Institute for Health Outcomes and Process Evaluation Research (iHope International), Kyoto, Japan.

Kiyomi Osako (K)

Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.

Yugo Shibagaki (Y)

Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.

Tsutomu Sakurada (T)

Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan. sakurada@marianna-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH